Fosun International LTD Eiger Bio Pharmaceuticals, Inc. Transaction History

Fosun International LTD

  • $138 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$9.59 - $12.0 $1.39 Million - $1.74 Million
-145,188 Closed
0 $0
Q1 2019

May 10, 2019
SELL
$10.31 - $14.38 $377,603 - $526,667
-36,625 Reduced 20.14%
145,188 $1.97 Million
Q4 2018

Jan 31, 2019
BUY
$8.63 - $12.4 $1.57 Million - $2.25 Million
181,813 New
181,813 $1.69 Million

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $496M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email